Pharmacokinetics of ibutilide and its enantiomers in dogs

Chirality

Volumn 8, Issue 1, 1996, Pages 18-23

  Hsu, Chang Yuan L ^a   Walters, Rodney R ^a  

^a PFIZER INC   (United States)

Author keywords

bioavailability; enantiomer; ibutilide; pharmacokinetic; racemate

Indexed keywords

IBUTILIDE FUMARATE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; CONFERENCE PAPER; DOG; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG METABOLISM; ENANTIOMER; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BIOLOGICAL AVAILABILITY; DOGS; FEMALE; INJECTIONS, INTRAVENOUS; MALE; STEREOISOMERISM; SULFONAMIDES;

EID: 0029926455     PISSN: 08990042     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-636X(1996)8:1<18::AID-CHIR5>3.0.CO;2-C     Document Type: Conference Paper

References (8)

1. Hester, J.B., Gibson, J.K., Cimini, M.G., Emmert, D.E., Locker, P.K., Perricone, S.C., Skaletzky, L.L., Sykes, J.K., West, B.E. N-[(ω-amino-1-hydroxyalkyl)phenyl]methanesulfonamide derivatives with Class III antiarrhythmic activity. J. Med. Chem. 34:308-315, 1991.
2. Cimini, M.G., Brunden, M.N., Gibson, J.K. Effects of ibutilide fumarate, a novel antiarrhythmic agent, and its enantiomers on isolated rabbit myocardium. Eur. J. PharmacoL 222:93-98, 1992.
3. Buchanan, L.V., Turcotte, U.M., Kabell, G.G., Gibson, J.K. Antiarrhythmic and electrophysiologic effects of ibutilide in a chronic canine model of atrial flutter. J. Cardiovasc. Pharmacol. 33:10-14, 1993.
4. Hsu, C.L., Walters, R.R. Assay of the enantiomers of ibutilide and artilide using solid-phase extraction, derivatization, and achiral-chiral column-switching high-performance liquid chromatography. J. Chromatogr. B. 667: 115-128, 1995.
5. Gibaldi, M., Perrier, D. Pharmacokinetics, 2nd ed. New York: Marcel Dekker, 1982.
6. Bombardt, P.A., Johnson, M.G. The Upjohn Co., Kalamazoo, Michigan. Personal communication.
7. Thornburgh, B.A., WickremaSinha, A.J. The Upjohn Co., Kalamazoo, Michigan. Personal communication.
8. Hussein, Z., Mulford, D.J., Bopp, B.A., Granneman, G.R. Differences in the stereoselective pharmacokinetics of pazinaclone (DN-2327), a new anxiolytic, and its active metabolite after intravenous and oral single doses to dogs. Drug Metab. Dispos. 21:805-810, 1993.